Minerva Surgical (NASDAQ:UTRS – Get Rating) announced its quarterly earnings results on Wednesday. The company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.31) by ($0.07), MarketWatch Earnings reports. Minerva Surgical updated its FY 2022 guidance to EPS.
UTRS stock opened at $1.75 on Friday. The business’s 50-day moving average is $4.06 and its two-hundred day moving average is $5.40. Minerva Surgical has a 1 year low of $1.64 and a 1 year high of $10.37. The company has a quick ratio of 2.60, a current ratio of 3.29 and a debt-to-equity ratio of 0.89.
Several analysts recently issued reports on the stock. Piper Sandler reduced their price objective on shares of Minerva Surgical from $12.00 to $6.00 in a report on Thursday. Zacks Investment Research lowered shares of Minerva Surgical from a “buy” rating to a “hold” rating in a report on Saturday, March 12th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $10.50.
Minerva Surgical Company Profile (Get Rating)
Minerva Surgical, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.
- Get a free copy of the StockNews.com research report on Minerva Surgical (UTRS)
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
- Carvana Insiders Buy Shares But Maybe You Shouldn’t
- Dutch Bros Gets Scalded By Inflation
Receive News & Ratings for Minerva Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Minerva Surgical and related companies with MarketBeat.com's FREE daily email newsletter.